Literature DB >> 17262712

Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

R Scott McClelland1, Laura Sangare, Wisal M Hassan, Ludo Lavreys, Kishorchandra Mandaliya, James Kiarie, Jeckoniah Ndinya-Achola, Walter Jaoko, Jared M Baeten.   

Abstract

We conducted a prospective study among women in Mombasa, Kenya, to determine whether Trichomonas vaginalis infection was associated with an increased risk of human immunodeficiency virus type 1 (HIV-1) infection. At monthly follow-up visits, laboratory screening for HIV-1 and genital tract infections was conducted. Among 1335 HIV-1-seronegative women monitored for a median of 566 days, there were 806 incident T. vaginalis infections (23.6/100 person-years), and 265 women seroconverted to HIV-1 (7.7/100 person-years). Trichomoniasis was associated with a 1.52-fold (95% confidence interval, 1.04-2.24-fold) increased risk of HIV-1 acquisition after adjustment for potential confounding factors. Treatment and prevention of T. vaginalis infection could reduce HIV-1 risk in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262712     DOI: 10.1086/511278

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  192 in total

1.  Incidence of sexually transmitted infections among hazardously drinking women after incarceration.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson
Journal:  Womens Health Issues       Date:  2011-08-10

Review 2.  Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections.

Authors:  Faye Korich; Neha G Reddy; Maria Trent
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

3.  Trichomonas vaginalis infection: can we afford to do nothing?

Authors:  R Scott McClelland
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

4.  Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Authors:  Julie B Dumond; Rosa F Yeh; Kristine B Patterson; Amanda H Corbett; Byung Hwa Jung; Naser L Rezk; Arlene S Bridges; Paul W Stewart; Myron S Cohen; Angela D M Kashuba
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

5.  Genital tract leukocytes and shedding of genital HIV type 1 RNA.

Authors:  Brenna L Anderson; Chia-Ching Wang; Allison K Delong; Tao Liu; Erna Milu Kojic; Jaclynn Kurpewski; Jessica Ingersoll; Kenneth Mayer; Angela M Caliendo; Susan Cu-Uvin
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

6.  Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.

Authors:  Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

Review 7.  Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Authors:  Jenell S Coleman; Charlotte A Gaydos; Frank Witter
Journal:  Obstet Gynecol Surv       Date:  2013-01       Impact factor: 2.347

8.  Trichomonas vaginalis contact-dependent cytolysis of epithelial cells.

Authors:  Gila Lustig; Christopher M Ryan; W Evan Secor; Patricia J Johnson
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

9.  Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.

Authors:  Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

10.  Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women.

Authors:  Lucia Pattullo; Sarah Griffeth; Lili Ding; Joel Mortensen; Jennifer Reed; Jessica Kahn; Jill Huppert
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.